This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

A buffet of emerging biotech at 2015 BIO Innovation Zone

June 10th, 2015
A buffet of emerging biotech at 2015 BIO Innovation Zone
NSF spurs the translation of fundamental research into innovation through investment in high-tech small businesses and in broad-based, regional collaborations between academia and industry. Shown here is an image from GigaGen Inc., an NSF-funded small business that is creating novel natural antibody therapeutics. GigaGen is one of nearly 40 NSF grantees participating in the 2015 BIO Innovation Zone, an exhibit space dedicated to businesses with cutting-edge biomedical technologies supported by NSF's Directorate for Engineering. Credit: GigaGen Inc.

For at least three days this month, Philadelphia will be the Silicon Valley of biotech.

Nearly 40 startups and small businesses funded by the National Science Foundation (NSF) with innovative biomedical technologies based on fundamental research will be in Philadelphia June 15-18 at the 2015 BIO International Convention, the world's largest gathering of the biotechnology industry.

The companies will be part of the Innovation Zone, a 5,000-square-foot exhibit space dedicated to businesses with cutting-edge biomedical technologies supported by NSF's Directorate for Engineering.

Most of the exhibitors are companies supported through the NSF Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) program, a $160-million activity that catalyzes the commercialization of high-risk technological innovations via research and development grants to small businesses and startups.

"Biomedical innovations born out of the ingenuity of inventors, scientists and engineers have the potential to benefit human health and boost the economy—if they make it to the marketplace," said Pramod Khargonekar, assistant director for engineering. "NSF seed funding provides the critical first step, while the Innovation Zone gathers potential investors, partners and mentors all under one roof, at one time, to make connections for commercialization. There is no substitute for this kind of in-person opportunity."

The zone will also include companies supported by the National Institutes of Health SBIR/STTR program, meaning more than 75 companies in all will showcase emerging biotech at the convention.

"BIO is thrilled to partner once again with the National Science Foundation to bring the Innovation Zone to Philadelphia this year, and we are excited to announce that we are doubling its size for the 2015 Convention," said Scott Whitaker, president of the BIO International Convention. "The Innovation Zone will serve as an exhibition of inspiration, highlighting an array of different technologies with powerful promise to make a difference in the lives of patients."

New university presence

The Innovation Zone was first launched at the 2014 BIO Convention.

This year, it will also feature six universities funded under the NSF Partnerships for Innovation: Accelerating Innovation Research program (PFI:AIR). This group will demonstrate advanced biomedical prototypes that are close to commercialization stage.

"It is exciting to see the PFI:AIR program represented in the Innovation Zone this year," said Barbara Kenny, NSF PFI:AIR program director. "These grantees have taken their NSF-funded research results and moved them toward societal use and commercial applications to the point where they can be showcased to potential investors."

The biotechnology developed by the PFI:AIR and SBIR/STTR grantees spans the spectrum from diagnostics and monitoring to drug discovery to manufacturing and treatments.

"The significant expansion of the Innovation Zone this year is indicative of the incredible value these disruptive technologies can bring to society, the investor community and the marketplace," said Jesus Soriano, a program director for NSF's SBIR/STTR program. "Biomedical and smart health startup companies funded by NSF leverage taxpayer dollars by raising significant private funds and establishing partnerships with key market players."

Legacy of support

NSF's role in the Innovation Zone is a continuation of a three-decade legacy of support for innovation and the high-tech small business community. In particular, large-scale trade shows provide exhibitors with opportunities to connect with a multitude of likeminded partners and investors.

Provided by National Science Foundation

Citation: A buffet of emerging biotech at 2015 BIO Innovation Zone (2015, June 10) retrieved 29 March 2024 from https://sciencex.com/wire-news/195400897/a-buffet-of-emerging-biotech-at-2015-bio-innovation-zone.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.